Vitamin D3 resolved human and experimental asthma via B lymphocyte–induced maturation protein 1 in T cells and innate lymphoid cells

This is the authors' abstract. We don't add key points for this paper.

Background Vitamin D 3 (VitD 3 ) is known to have immunomodulatory functions, and VitD 3 deficiency is associated with more severe asthma. Objective We aimed to assess the immunoregulatory effects of VitD 3 food supplementation on asthma manifestation, with particular focus on T cells and type 2 innate lymphoid cells. Methods Preschool children and adult asthmatic cohorts were analyzed in the context of VitD 3 supplementation and serum levels. In a murine model of ovalbumin-induced asthma, effects of diet VitD 3 sufficiency and deficiency on T cells and type 2 innate lymphoid cells immune mechanisms were investigated. Results We found less severe and better-controlled asthma phenotypes along with reduced need for steroid medication in preschool children and asthmatic adults with VitD 3 supplementation. VitD 3 serum levels correlated with B lymphocyte–induced maturation protein 1 (Blimp-1) expression in blood peripheral mononuclear cells. VitD 3 -supplement–fed mice showed decreased asthmatic traits, with a decrease in IgE serum levels, reduced airway mucus, and increased IL-10 production by lung cells. Furthermore, we discovered an upregulation of effector T cells and Blimp-1 + lung tissue-resident memory T cells as well as induction of anti-inflammatory Blimp-1 + lung innate lymphoid cells producing IL-10. Conclusion Supplementing VitD 3 resulted in amelioration of clinical asthma manifestations in human studies as well as in experimental allergic asthma, indicating that VitD 3 shifts proinflammatory immune responses to anti-inflammatory immune responses via upregulating Blimp-1 in lung innate lymphoid cells and tissue-resident memory cells.